Cognitive and behavioral effects of quetiapine in Alzheimer disease patients

Alzheimer Disease and Associated Disorders

Volumn 16, Issue 2, 2002, Pages 128-130

  Scharre, Douglas W ^a   Chang, Shu Ing ^a  

^a 471 Means Hall ^*  (United States)

Author keywords

Aggression; Alzheimer disease; Behaviors; Cognition; Psychosis; Quetiapine

Indexed keywords

QUETIAPINE;

ADULT; AGED; AGGRESSION; ALZHEIMER DISEASE; ANTICHOLINERGIC EFFECT; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; DELUSION; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RISK BENEFIT ANALYSIS; SCORING SYSTEM;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; TREATMENT OUTCOME;

EID: 0036283590     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200204000-00011     Document Type: Article

References (10)

1. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
2. "Seroquel" (quetiapine fumarate) may reduce hostility in patients with psychosis related to Alzheimer's disease
3. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
4. Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders
5. Alzheimer's Disease Assessment Scale (ADAS)
6. Seroquel: Biochemical profile of a potential atypical antipsychotic
7. Quetiapine in patients with schizophrenia: A high- and low-dose double-blind comparison with placebo
8. A longitudinal study of Alzheimer's disease: Measurement, rate and predictors of cognitive deterioration
9. Seroquel and cognitive improvement in patients with schizophrenia
10. Long-term use of quetiapine in elderly patients with psychotic disorders